348 related articles for article (PubMed ID: 2881873)
21. [Barrett esophagus. Current situation of the risk and surveillance policy].
Robaszkiewicz M
Presse Med; 1994 Dec; 23(40):1846-8. PubMed ID: 7899314
[TBL] [Abstract][Full Text] [Related]
22. Review article: prevalence of Barrett's oesophagus and metaplasia at the gastro-oesophageal junction.
Sharma P
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():48-54; discussion 61-2. PubMed ID: 15456464
[TBL] [Abstract][Full Text] [Related]
23. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L in Barrett's esophagus with dysplasia and adenocarcinoma.
Popnikolov NK; Gatalica Z; Adegboyega PA; Norris BA; Pasricha PJ
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):161-5. PubMed ID: 16785783
[TBL] [Abstract][Full Text] [Related]
25. Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?
Fitzgerald RC
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i21-6. PubMed ID: 15711004
[TBL] [Abstract][Full Text] [Related]
26. GATA6 expression in Barrett's oesophagus and oesophageal adenocarcinoma.
Pavlov K; Honing J; Meijer C; Boersma-van Ek W; Peters FT; van den Berg A; Karrenbeld A; Plukker JT; Kruyt FA; Kleibeuker JH
Dig Liver Dis; 2015 Jan; 47(1):73-80. PubMed ID: 25445407
[TBL] [Abstract][Full Text] [Related]
27. Columnar lined oesophagus and intestinal metaplasia: current concepts.
Wolf C; Timmer R; Breumelhof R; Seldenrijk CA; Smout AJ
Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):793-800. PubMed ID: 10445803
[TBL] [Abstract][Full Text] [Related]
28. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma.
Morita S; Matsumoto Y; Okuyama S; Ono K; Kitamura Y; Tomori A; Oyama T; Amano Y; Kinoshita Y; Chiba T; Marusawa H
Carcinogenesis; 2011 Nov; 32(11):1706-12. PubMed ID: 21890457
[TBL] [Abstract][Full Text] [Related]
29. Experimental columnar metaplasia in the canine oesophagus.
Gillen P; Keeling P; Byrne PJ; West AB; Hennessy TP
Br J Surg; 1988 Feb; 75(2):113-5. PubMed ID: 3349294
[TBL] [Abstract][Full Text] [Related]
30. Expression profile and cellular localizations of mucin proteins, CK7, and cytoplasmic p27 in Barrett's esophagus and esophageal adenocarcinoma.
Ozcan HEA; Anuk T; Ozden O
Adv Med Sci; 2018 Sep; 63(2):296-300. PubMed ID: 29803118
[TBL] [Abstract][Full Text] [Related]
31. Histological and histochemical changes in the columnar lined (Barrett's) oesophagus.
Rothery GA; Patterson JE; Stoddard CJ; Day DW
Gut; 1986 Sep; 27(9):1062-8. PubMed ID: 3758820
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical analysis of metaplastic non-goblet columnar lined oesophagus shows phenotypic similarities to Barrett's oesophagus: a study in an Asian population.
Srivastava S; Liew MS; McKeon F; Xian W; Yeoh KG; Ho KY; Teh M
Dig Liver Dis; 2014 Feb; 46(2):170-5. PubMed ID: 24290871
[TBL] [Abstract][Full Text] [Related]
33. Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma.
Bobryshev YV; Freeman AK; Botelho NK; Tran D; Levert-Mignon AJ; Lord RV
Dis Esophagus; 2010 Sep; 23(7):580-9. PubMed ID: 20459440
[TBL] [Abstract][Full Text] [Related]
34. Barrett's oesophagus: the new endoscopic modalities have a future.
Deviere J
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i33-7. PubMed ID: 15711006
[TBL] [Abstract][Full Text] [Related]
35. Proliferating cell nuclear antigen in oesophageal diseases; correlation with transforming growth factor alpha expression.
Jankowski J; McMenemin R; Yu C; Hopwood D; Wormsley KG
Gut; 1992 May; 33(5):587-91. PubMed ID: 1351861
[TBL] [Abstract][Full Text] [Related]
36. Controversies of the cardiac mucosa and Barrett's oesophagus.
Chandrasoma P
Histopathology; 2005 Apr; 46(4):361-73. PubMed ID: 15810947
[TBL] [Abstract][Full Text] [Related]
37. Adenocarcinoma in columnar-lined Barrett's esophagus. Analysis of 13 esophagectomies.
Saubier EC; Gouillat C; Samaniego C; Guillaud M; Moulinier B
Am J Surg; 1985 Sep; 150(3):365-9. PubMed ID: 4037198
[TBL] [Abstract][Full Text] [Related]
38. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
39. K-ras point mutations are rare events in premalignant forms of Barrett's oesophagus.
Trautmann B; Wittekind C; Strobel D; Meixner H; Keymling J; Gossner L; Ell C; Hahn EG
Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):799-804. PubMed ID: 8864678
[TBL] [Abstract][Full Text] [Related]
40. Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk.
Kelty CJ; Gough MD; Van Wyk Q; Stephenson TJ; Ackroyd R
Scand J Gastroenterol; 2007 Nov; 42(11):1271-4. PubMed ID: 17852872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
